Trial Profile
A Single-site, Open-label, Fixed-sequence Phase 1 Study Evaluating the Effect of Eliglustat (Genz-112638) on the Pharmacokinetics, Safety and Tolerability of Metoprolol in Healthy Adult Subjects.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Eliglustat (Primary) ; Metoprolol
- Indications Gaucher's disease type I
- Focus Pharmacokinetics
- Sponsors Genzyme Corporation
- 27 Nov 2013 New trial record